Xlife Sciences AG
SIX:XLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xlife Sciences AG
SIX:XLS
|
CH |
|
Percheron Therapeutics Ltd
ASX:PER
|
AU |
|
M
|
Mida Assets PCL
SET:MIDA
|
TH |
|
Kruk SA
F:83I
|
PL |
|
S
|
Sammakorn PCL
SET:SAMCO
|
TH |
|
Van de Velde NV
F:VO4
|
BE |
Intrinsic Value
Is XLS undervalued or overvalued?
See the intrinsic value estimate for Xlife Sciences AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
XLS looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with XLS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Xlife Sciences Does
Xlife Sciences AG is a Swiss life-sciences company that helps turn research ideas into commercial products. It works with universities, hospitals, and researchers to identify promising technologies, then supports their development into new medicines, diagnostics, medical devices, and related health products. In practice, it acts as a bridge between academic research and the market.
- Headquarters
- Switzerland CH
- Employees
- 19
- IPO date
- Sep 30, 2019
Earnings Waterfall
Xlife Sciences AG
The intrinsic value for Xlife Sciences AG (XLS) under the Base Case is hidden CHF.
Compared with the current market price of 9.9 CHF, the stock appears hidden.